In order to design an injectable formulation of E5531, a novel synthetic disaccharide analog of novel lipid A, for the treatment of septic shock, a ‘pH-jump method’ was developed. In this method, E5531 was dispersed in 0.003 mol/L NaOH (pH 11.0, above pK_a2) at 50^oC (above phase transition temperature) and then mixed with a buffer to neutralize the pH to 7.3. E5531 was dispersed as particles, and the size was approximately 20 nm. The structure of the particles was vesicular. After dispersal, the dispersion was sterilized using a filter, filled aseptically into vials, and lyophilized. The size of the particles did not change after lyophilization. The relationship between the physicochemical properties of the particles and the pharmacokinetics in rats after intravenous administration was investigated. The membrane fluidity of the particles was affected by the dispersal methods, the dispersal time in 0.003 N NaOH in the pH-jump method, and the addition of Ca²⁺ to the solution. The membrane fluidity was correlated with the pharmacokinetics in rats.